270 related articles for article (PubMed ID: 2554155)
1. Ventricular and atrial electrophysiological effects of a IC antiarrhythmic drug, cibenzoline, in the innervated dog heart. Role of sodium and calcium channels.
Timour Q; Aupetit JF; Loufoua-Moundanga J; Bertrix L; Freysz M; Faucon G
Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):338-44. PubMed ID: 2554155
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog.
Leboeuf J; Basiez M; Massingham R
Br J Pharmacol; 1993 Sep; 110(1):23-8. PubMed ID: 8220882
[TBL] [Abstract][Full Text] [Related]
3. Changes in atrial and ventricular refractoriness and in atrioventricular nodal conduction produced by combinations of vagal and sympathetic stimulation that result in a constant spontaneous sinus cycle length.
Inoue H; Zipes DP
Circ Res; 1987 Jun; 60(6):942-51. PubMed ID: 3594761
[TBL] [Abstract][Full Text] [Related]
4. Cardiac electrophysiological effects of cibenzoline in the conscious dog: plasma concentration-response relationships.
Boucher M; Dubray C; Kantelip JP; Talmant JM; Dufour A; Duchêne-Marullaz P
J Cardiovasc Pharmacol; 1989 Oct; 14(4):616-21. PubMed ID: 2478775
[TBL] [Abstract][Full Text] [Related]
5. Effects on rabbit nodal, atrial, ventricular and Purkinje cell potentials of a new antiarrhythmic drug, cibenzoline, which protects against action potential shortening in hypoxia.
Millar JS; Vaughan Williams EM
Br J Pharmacol; 1982 Mar; 75(3):469-78. PubMed ID: 7066601
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiologic effects of bepridil in the anesthetized dog studied by endocardiac electrodes.
Sassine A; Masse C; Fajuri A; Hirsch JL; Labrid C; Puech P
Am J Cardiol; 1984 Jun; 53(11):1707-11. PubMed ID: 6610347
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiologic effects of cibenzoline in humans related to dose and plasma concentration.
Touboul P; Atallah G; Kirkorian G; de Zuloaga C; Dufour A; Aymard MF; Lavaud P; Moleur P
Am Heart J; 1986 Aug; 112(2):333-9. PubMed ID: 3526853
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological mapping of regional effects in the rabbit heart of some new antiarrhythmic drugs.
Millar JS; Vaughan Williams EM
Br J Pharmacol; 1983 Jul; 79(3):701-9. PubMed ID: 6652350
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiological effects of penticainide in the anaesthetized dog.
Sassine A; Brugada J; Munoz A; Romero-Ayala L; Masse C
Drugs Exp Clin Res; 1987; 13(1):15-20. PubMed ID: 3595440
[TBL] [Abstract][Full Text] [Related]
10. Canine electrophysiology of encainide, a new antiarrhythmic drug.
Sami M; Mason JW; Oh G; Harrison DC
Am J Cardiol; 1979 Jun; 43(6):1149-54. PubMed ID: 443174
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart.
Fazekas T; Carlsson L; Scherlag BJ; Mabo P; Poty H; Palmer M; Patterson E; Berlin KD; Garrison GL; Lazzara R
J Cardiovasc Pharmacol; 1996 Aug; 28(2):182-91. PubMed ID: 8856472
[TBL] [Abstract][Full Text] [Related]
12. The electrophysiological effects of dicentrine on the conduction system of rabbit heart.
Young ML; Su MJ; Wu MH; Chen CC
Br J Pharmacol; 1994 Sep; 113(1):69-76. PubMed ID: 7812635
[TBL] [Abstract][Full Text] [Related]
13. The influence of elevated Mg2+ concentrations on cardiac electrophysiologic parameters.
Stark G; Stark U; Pilger E; Hönigl K; Bertuch H; Tritthart HA
Cardiovasc Drugs Ther; 1989 Apr; 3(2):183-9. PubMed ID: 2484855
[TBL] [Abstract][Full Text] [Related]
14. Clinical electrophysiology of intravenous sotalol, a beta-blocking drug with class III antiarrhythmic properties.
Touboul P; Atallah G; Kirkorian G; Lamaud M; Moleur P
Am Heart J; 1984 May; 107(5 Pt 1):888-95. PubMed ID: 6720518
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological effects of carocainide (770207) on the dog heart.
Huerta F; Santamaria R; Pourrias B
Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):289-98. PubMed ID: 6712362
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal polypeptide facilitates atrioventricular nodal conduction and shortens atrial and ventricular refractory periods in conscious and anesthetized dogs.
Rigel DF; Lathrop DA
Circ Res; 1990 Dec; 67(6):1323-33. PubMed ID: 2245498
[TBL] [Abstract][Full Text] [Related]
17. Investigations to characterize a new antiarrhythmic drug bisaramil.
Paroczai M; Karpati E
Pharmacol Res; 1991 Aug; 24(2):149-62. PubMed ID: 1684242
[TBL] [Abstract][Full Text] [Related]
18. Multiple cellular electrophysiological effects of a novel antiarrhythmic furoquinoline derivative HA-7 [N-benzyl-7-methoxy-2,3,4,9-tetrahydrofuro[2,3-b]quinoline-3,4-dione] in guinea pig cardiac preparations.
Chang GJ; Su MJ; Kuo SC; Lin TP; Lee YS
J Pharmacol Exp Ther; 2006 Jan; 316(1):380-91. PubMed ID: 16174797
[TBL] [Abstract][Full Text] [Related]
19. Cardiac electrophysiologic effects of etafenone hydrochloride (Dialicor), a new antiarrhythmic agent.
Toda H; Watanabe Y
J Electrocardiol; 1979 Jul; 12(3):283-93. PubMed ID: 469443
[TBL] [Abstract][Full Text] [Related]
20. Cardiac effects of amiloride in the dog.
Yamashita S; Motomura S; Taira N
J Cardiovasc Pharmacol; 1981; 3(4):704-15. PubMed ID: 6167801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
